Our study investigates the hypothesis that DSS ameliorates AD pathology via AMPK/Sp1/ACSL4 axis-mediated regulation of neuronal lipid metabolism and ferroptosis suppression, using the APP/PS1 transgenic mouse model. This evidence concerns the gene APP and Alzheimer disease.